Women's and Children's Hospital

The Hon. C.M. SCRIVEN (14:45): Will any pathology, pharmacy or other staff jobs at the Women's and Children's Hospital be at risk due to shared services between the RAH and the Women's and Children's Hospital?

The Hon. S.G. WADE (Minister for Health and Wellbeing) (14:45): The briefing I referred to earlier identified that there were opportunities to reduce the costs, as I understood it, particularly of the build through the opportunity for Shared Services; in other words, if you have an SA Pathology facility in the Royal Adelaide Hospital site there may well be pathology that could be delivered from the SA Pathology laboratory and the current RAH site into the Women's and Children's Hospital.

Of course, the most significant development since this briefing was written, in relation to pathology, is this government's commitment to provide a new laboratory for SA Pathology, a major capital investment in continuing to build on the exemplary world-class pathology services provided by SA Pathology during the pandemic, and delivering world-class services for whatever may come.

The work that has been done in relation to the SA Pathology business case, for its development, and the work that has been done in relation to the new Women's and Children's Hospital business case will interface, and we will make sure we get the best value for money for taxpayers in terms of the build and the operation and we will also make sure we continue to deliver world-class health services.

The PRESIDENT: Supplementary, the Hon. Ms Scriven.